TY - JOUR T1 - Optimising treatment for post-operative lung cancer recurrence JF - European Respiratory Journal JO - Eur Respir J SP - 374 LP - 378 DO - 10.1183/13993003.01490-2015 VL - 47 IS - 2 AU - Dragan Subotic AU - Paul Van Schil AU - Bogdan Grigoriu Y1 - 2016/02/01 UR - http://erj.ersjournals.com/content/47/2/374.abstract N2 - Surgical treatment offers the best chances for long-term survival in patients with primary nonsmall cell lung cancer (NSCLC). However, long-term survival after surgery remains less than 50%, mostly due to a 30–77% rate of tumour recurrence. Unlike the distant type of recurrence that is treated nonsurgically in the vast majority of patients, local or loco-regional recurrence, which occurs in 4.6–24% of patients after complete resection (∼80% of cases in the first 2 years) [1], raises several concerns related to the optimal therapeutic approach.The second lung resection is a valuable option for post-operative lung cancer recurrence http://ow.ly/U8z3c ER -